(a) Mice were treated with drinking water with or without DSS
2% (w/v) for 5 days and euthanized on day 12 for analysis. DSS-treated
Trpm8−/− mice showed
significantly increased body weight loss, and, (b) significantly
increased DAI scores compared to WT mice. (c) Increased epithelial
damage and inflammatory cell infiltration in the distal colon in DSS treated
Trpm8−/− mice compared to WT
mice. Representative cross-sections of the distal colons of WT and
Trpm8−/− mice after water or
DSS treatment, respectively (H&E staining). No differences were observed
between both genotypes in water controls. (d) Significantly
increased mean colitis score in DSS treated
Trpm8−/− versus WT mice, as
determined by histological analysis. (e) Significantly increased
ulcerated area of colonic mucosa in DSS treated
Trpm8−/− compared to WT
mice. (f) Increased production of pro-inflammatory cytokines
(TNF-α, IL-1β and IL-6) in colonic explants from DSS treated
Trpm8−/− mice compared to WT
mice. Of these inflammatory mediators, only IL-6 was detected in colon explant
cultures taken from water treated (control) animals. (g) WT and
Trpm8−/− mice were subjected
to DSS 1% (DSSlow) for 5 days and euthanized on day 10. Only
Trpm8−/− mice showed
significant body weight loss and, (h) elevated DAI scores after
DSSlow treatment. (i)
Trpm8−/− but not WT mice showed
mucosal damage and inflammatory activity after DSSlow treatment.
(j) Significantly increased pro-inflammatory cytokine
production by colonic explants from
Trpm8−/− mice. Data are mean
± SEM and representative of 3 independent experiments.
*P<0.05 by 2-way ANOVA (a, g) or Mann-Whitney
(b, d–f, h, j). Scale bars = 100 μm (c, i).